Kilian Schober
@kischober.bsky.social
1.8K followers 230 following 91 posts
MD Microbiology & Virology. Understanding & Engineering Human T Cell Immunity in Erlangen, Germany (www.schoberlab.de). Cycling. BVB. Cinema. Family.
Posts Media Videos Starter Packs
Pinned
kischober.bsky.social
When a T cell carries both its natural TCR and an engineered CAR, do these two receptors cooperate - or compete?

Our new preprint on bioRxiv shows that TCR activation can enhance CAR-T activation but impairs CAR-mediated killing when targets are on separate cells.

www.biorxiv.org/content/10.1...
TCR activation impairs CAR-T cytotoxicity against separate target cells
Chimeric antigen receptor T cells (CAR-T) are effective therapeutics against cancer and autoimmunity, but whether the endogenous T cell receptor (TCR) is beneficial, detrimental or irrelevant for CAR ...
www.biorxiv.org
Reposted by Kilian Schober
labwaggoner.bsky.social
@biorxivpreprint.bsky.social TCR activation impairs CAR-T cytotoxicity against separate target cells
www.biorxiv.org/content/10.1...
Reposted by Kilian Schober
jorg-vogel-lab.bsky.social
Two group leader positions available in the broader areas of RNA science, RNA technologies, and RNA medicine. Attractive packages and a great environment. Come and join us at Helmholtz RNA Würzburg, Bavaria.
Reposted by Kilian Schober
ourworldindata.org
Declining child mortality, fast and slow
The image depicts a line chart illustrating child mortality rates, specifically the estimated percentage of newborns who do not survive past the age of five. The chart has two distinct lines: one representing Sweden in blue and the other representing South Korea in red. 

Starting in the early 1800s, the blue line for Sweden shows a gradual decline in the child mortality rate, fluctuating around 35% at the beginning and continuing to decrease steadily over the years, reaching nearly 0% by 2023. 

In contrast, the red line for South Korea begins more steeply in the mid-20th century, experiencing a rapid decline after 1950, ultimately approaching a very low percentage by 2023. 

The sources for the data are listed at the bottom as Gapminder (2015) and the UN Inter-agency Group for Child Mortality Estimation (2025). The entire chart is labeled as CC BY for Creative Commons licensing.
Reposted by Kilian Schober
saligramalab.bsky.social
Does #bluesky still #exist or is it #dead?
Reposted by Kilian Schober
fau.de
Einem Ärzteteam des Uniklinikums Erlangen ist es weltweit erstmals gelungen, eine junge Patientin mit therapieresistenter, schwerer chronisch-entzündlicher Darmerkrankung erfolgreich mit einer CAR-T-Zell-Therapie zu behandeln.

Mehr erfahren: go.fau.de/1cb-e
CAR-T-Zell-Therapie erstmals bei schwerer Darmerkrankung erfolgreich
Einem Ärzteteam am Deutschen Zentrum Immuntherapie des Uniklinikums Erlangen ist es weltweit erstmals gelungen, eine junge Patientin mit therapieresistenter…
go.fau.de
Reposted by Kilian Schober
biorxiv-immuno.bsky.social
TCR activation impairs CAR-T cytotoxicity against separate target cells https://www.biorxiv.org/content/10.1101/2025.10.07.680634v1
kischober.bsky.social
When a T cell carries both its natural TCR and an engineered CAR, do these two receptors cooperate - or compete?

Our new preprint on bioRxiv shows that TCR activation can enhance CAR-T activation but impairs CAR-mediated killing when targets are on separate cells.

www.biorxiv.org/content/10.1...
TCR activation impairs CAR-T cytotoxicity against separate target cells
Chimeric antigen receptor T cells (CAR-T) are effective therapeutics against cancer and autoimmunity, but whether the endogenous T cell receptor (TCR) is beneficial, detrimental or irrelevant for CAR ...
www.biorxiv.org
kischober.bsky.social
I think often the prizes also go to people who were first authors or trainees at the time of the discovery (or the seminal paper) if there was one, so were not PIs at the time. There is no easy solution because if you award 10 people instead of 2-3, person #11 ans #12 will be treated „unfairly“.
kischober.bsky.social
Congrats to you for your work and for congratulating the winners although could have been among them.
Reposted by Kilian Schober
fau.de
Killerzellen des Immunsystems vermehren sich, wenn sie auf eine Infektion stoßen, um diese zu bekämpfen. Allerdings gilt das nicht für jede Killerzelle. Woran liegt es, ob es zur Vermehrung kommt oder nicht? FAU-Forschende sind dieser Frage nachgegangen.

www.fau.de/2025/10/news...
Killerzellen: Wie das Immunsystem seine Abwehrtruppen auswählt
Wenn Killerzellen des Immunsystems auf Anzeichen einer Infektion stoßen, teilen sich manche von ihnen danach rasant. Sie wachsen so zu einer großen Abwehrtruppe heran, die dann den Erreger bekämpft.
www.fau.de
kischober.bsky.social
“I was never working alone—there were people all over the world who shared similar ideas,” he said. “I see this award as one that represents all of those people who have contributed to this research alongside me.”

Prices go to individual people, but Sakaguchi shows how to acknowledge the field.
Reposted by Kilian Schober
jsabatino37.bsky.social
A really nice overview of key Treg discoveries relevant for today's exciting Nobel announcement
www.nobelprize.org/uploads/2025...
www.nobelprize.org
kischober.bsky.social
Thanks for highlighting!
Reposted by Kilian Schober
labwaggoner.bsky.social
Clonal recruitment after vaccination is governed by a TCR avidity threshold, whereas probabilistic expansion preserves repertoire polyclonality @sciimmunology.bsky.social
www.science.org/doi/10.1126/...
Reposted by Kilian Schober
immunoeditor.bsky.social
This week in #Science #Immunology! 👇
kischober.bsky.social
If the immune system is an army...
...
would you rather rely on one “super warrior” — or on a diverse team of fighters, even if none of them is the single strongest?

I’d go with the team.

Why? Check out our new study, just published in Science Immunology: www.science.org/doi/10.1126/...